These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 368769)

  • 21. Extracorporeal left ventricular assistance with prostacyclin and heparinized centrifugal pump.
    Palatianos GM; Edmunds LH; Cohen DJ; Stephenson LW
    Ann Thorac Surg; 1983 May; 35(5):504-15. PubMed ID: 6342555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
    Gainza FJ; Quintanilla N; Pijoan JI; Delgado S; Urbizu JM; Lampreabe I
    J Nephrol; 2006; 19(5):648-55. PubMed ID: 17136695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
    Longmore DB; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read NG; Vane JR
    Lancet; 1979 May; 1(8124):1002-5. PubMed ID: 86720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodialysis with the stable prostacyclin analogue CG 4203.
    Maurin N
    Prog Clin Biol Res; 1987; 242():479-84. PubMed ID: 3313422
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients.
    Kuźniewski M; Sułowicz W; Lisiewicz J
    Int Urol Nephrol; 1991; 23(1):89-96. PubMed ID: 1938222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
    Kerins DM; Murray R; FitzGerald GA
    Prog Hemost Thromb; 1991; 10():307-37. PubMed ID: 1848945
    [No Abstract]   [Full Text] [Related]  

  • 27. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
    Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of prostacyclin and heparin on hemodialyses in dogs.
    Gross M; Bush H; McTigue H; Hamburger RJ; Flamenbaum W
    Prostaglandins; 1981 Jun; 21(6):879-88. PubMed ID: 7027320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Lancet; 1980 Aug; 2(8188):219-22. PubMed ID: 6105392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostacyclin plus heparin reduces dialyser efficiency.
    Kalra PA; Wheeler D; Turney JH
    Nephrol Dial Transplant; 1988; 3(3):357-8. PubMed ID: 3140118
    [No Abstract]   [Full Text] [Related]  

  • 31. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a stable 5-F prostacyclin analogue as an antithrombotic agent in haemodialysis.
    Nicholson NS; Smith SL; Taite BB; Krueger A; Fuller GC
    Drugs Exp Clin Res; 1986; 12(5):371-5. PubMed ID: 3522158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation.
    Addonizio VP; Fisher CA; Bowen JC; Palatianos GC; Colman RW; Edmunds LH
    Trans Am Soc Artif Intern Organs; 1981; 27():304-7. PubMed ID: 7036500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin I2, indomethacin, and heparin promote postischemic neuronal recovery in dogs.
    Hallenbeck JM; Leitch DR; Dutka AJ; Greenbaum LJ; McKee AE
    Ann Neurol; 1982 Aug; 12(2):145-56. PubMed ID: 6751213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis.
    Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH
    Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation options for intermittent haemodialysis.
    Davenport A
    Minerva Urol Nefrol; 2006 Jun; 58(2):171-80. PubMed ID: 16767070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
    Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of prostacyclin in regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1980; 17():318-22. PubMed ID: 7017677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.